Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • December 9th, 2020 • Rose William • Pharmaceutical preparations
Contract Type FiledDecember 9th, 2020 Company IndustryThis letter, dated as of the date set forth on the signature page hereto, is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and one or more designated representatives (the “Representatives”) of the Underwriters named therein (the “Underwriters”), relating to an underwritten public offering of Class A common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Offering”).
Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • December 9th, 2020 • Rose William • Pharmaceutical preparations
Contract Type FiledDecember 9th, 2020 Company IndustryThis letter, dated as of the date set forth on the signature page hereto, is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and one or more designated representatives (the “Representatives”) of the Underwriters named therein (the “Underwriters”), relating to an underwritten public offering of Class A common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Offering”).
Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • November 20th, 2019 • Rose William • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2019 Company IndustryThis letter, dated as of the date set forth on the signature page hereto, is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and one or more designated representatives (the “Representatives”) of the Underwriters named therein (the “Underwriters”), relating to an underwritten public offering of Class A common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Offering”).
Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • November 20th, 2019 • Rose William • Pharmaceutical preparations
Contract Type FiledNovember 20th, 2019 Company IndustryThis letter, dated as of the date set forth on the signature page hereto, is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Reata Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and one or more designated representatives (the “Representatives”) of the Underwriters named therein (the “Underwriters”), relating to an underwritten public offering of Class A common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Offering”).
Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • July 31st, 2018 • Rose William • Pharmaceutical preparations
Contract Type FiledJuly 31st, 2018 Company Industry
Lock-Up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • July 31st, 2018 • Rose William • Pharmaceutical preparations
Contract Type FiledJuly 31st, 2018 Company Industry
Lock-up Agreement Reata Pharmaceuticals, Inc. Public Offering of Common StockLock-Up Agreement • August 2nd, 2017 • Rose William • Pharmaceutical preparations
Contract Type FiledAugust 2nd, 2017 Company Industry